Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors—A Single Center Experience in 152 Patients

Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors—A Single Center Experience in 152 Patients

ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (allo‐SCT) is a key treatment for hematologic malignancies, but donor selection impacts outcomes. Results In a cohort of 152 patients undergoing allo‐SCT from 2012 to 2023, haploidentical donors with post‐transplant cyclophospham...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Jäger, Benno Biermann, Nora Liebers, Felicitas Schulz, Ben‐Niklas Baermann, Sören Twarock, Stefanie Geyh, Kathrin Nachtkamp, Patrick Tressin, Annika Kasprzak, Felix Matkey, Titus Watrin, Malika El Yaouti, Ulrich Germing, Sascha Dietrich, Guido Kobbe
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:eJHaem
Subjects:
BMT
cellular therapies
hematological malignancies
transplant
Online Access:https://doi.org/10.1002/jha2.70012
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jha2.70012

Similar Items